Associated Papers
Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies.
Sidoti A et al.
Biology, 2024
Coding Variants of the FMO3 Gene Are Associated with the Risk of Chronic Kidney Disease: A Case-Control Study.
Shorudi Dadi I et al.
Reports of Biochemistry & Molecular Biology, 2022
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients.
Söderberg MM et al.
The Pharmacogenomics Journal, 2013
Flavin-containing monooxygenases: mutations, disease and drug response.
Phillips IR et al.
Trends in Pharmacological Sciences, 2008
Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3).
Allerston CK et al.
Pharmacogenetics and Genomics, 2007
The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.
Krueger SK et al.
Drug Metabolism Reviews, 2006
The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development.
Cashman JR
Drug Discovery Today, 2004
Select a paper to view details